Exsell Laboratories Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Exsell Laboratories Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $28.3K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Exsell Laboratories Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $28.3K Trade | TransData Nexus

Exsell Laboratories Private Limited

Indian Pharmaceutical Exporter · Antivirals Specialist · $28.3K Total Trade · DGFT Verified

Exsell Laboratories Private Limited is an Indian pharmaceutical exporter with a total trade value of $28.3K across 3 products in 3 therapeutic categories. Based on 29 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ribavirin ($15.2K), Ledipasvir ($9.8K), Chlorambucil ($3.3K).

Exsell Laboratories Private Limited — Export Portfolio & Destination Treemap

Exsell Laboratories Private Limited pharmaceutical export portfolio — 3 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is Exsell Laboratories Private Limited? — Company Overview & Market Position

Exsell Laboratories Private Limited is an Indian pharmaceutical exporter established in 2015 by Santosh Arun Singh, who serves as the Founder and Director. The company is registered under the Corporate Identification Number (CIN) U52520MH2017PTC291942, with its registered office located at A-1112, Centrum Business Square, Road No. 16, Thane, Maharashtra, India. Operating as a private limited company, Exsell Laboratories has an authorized capital of ₹100,000 INR and a paid-up capital of ₹100,000 INR. The company employs a team of experienced health professionals with a collective background of 15 years in the pharmaceutical international trade industry. Exsell Laboratories exports a diverse range of pharmaceutical products to over 45 countries, demonstrating its commitment to global expansion and adaptability.

What Does Exsell Laboratories Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Ribavirin$15.2K 2Ledipasvir$9.8K

Product Portfolio — Top 3 by Export Value

Exsell Laboratories Private Limited exports 3 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Ribavirin	Antivirals	$15.2K	12	2.4%	4
2	Ledipasvir	Antiviral & HIV Medications	$9.8K	8	0.9%	11
3	Chlorambucil	Advanced Oncology	$3.3K	9	1.0%	9

Exsell Laboratories Private Limited exports 3 pharmaceutical products across 3 therapeutic categories with a total export value of $28.3K. The top category is Antivirals (53.7% of portfolio), followed by Antiviral & HIV Medications (34.6%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Exsell Laboratories Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Exsell Laboratories Private Limited operates manufacturing facilities in Thane, Maharashtra, India. The company specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. While specific details regarding manufacturing capacities are not publicly disclosed, Exsell Laboratories boasts a diverse product portfolio of over 36,000 items, indicating substantial production capabilities. The company's manufacturing operations are designed to meet the requirements of hospitals, physicians, and other healthcare providers, ensuring a reliable supply of high-quality pharmaceutical products.

3Key Leadership

The leadership team at Exsell Laboratories Private Limited is headed by Santosh Arun Singh, the Founder and Director, who established the company in 2015. The company is also led by Arunkumar Mathuraprasad Singh, who serves as a Director. Under their guidance, Exsell Laboratories has expanded its global presence, exporting products to over 45 countries and offering a diverse range of over 36,000 pharmaceutical items. The leadership team's extensive experience in the pharmaceutical international trade industry has been instrumental in the company's growth and success.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Exsell Laboratories Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Exsell Laboratories Private Limited has established a significant presence in regulated markets, exporting pharmaceutical products to over 45 countries. While specific details regarding regulatory filings, approvals, and market access status in the United States, European Union, United Kingdom, Australia, and Japan are not publicly disclosed, the company's extensive global reach suggests compliance with international regulatory standards. Exsell Laboratories' commitment to quality and regulatory compliance is evident in its partnerships with hospitals, pharmacies, and governments worldwide, indicating adherence to stringent regulatory requirements in these markets.

2Emerging Markets

Exsell Laboratories Private Limited has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company's export activities to over 45 countries demonstrate its adaptability and commitment to global expansion. While specific details regarding WHO prequalification are not publicly disclosed, Exsell Laboratories' extensive product portfolio and global partnerships suggest a focus on meeting international standards, which is essential for accessing emerging markets. The company's dedication to quality control measures and adherence to international standards make it a preferred choice for healthcare providers worldwide.

Geographic Strategy

Exsell Laboratories Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Exsell Laboratories Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly disclosed. However, the company's extensive export activities to over 45 countries suggest compliance with international regulatory standards, including those of the FDA. Exsell Laboratories' commitment to quality and regulatory compliance is evident in its partnerships with hospitals, pharmacies, and governments worldwide, indicating adherence to stringent regulatory requirements.

2WHO & EU GMP

While specific details regarding Exsell Laboratories Private Limited's WHO prequalification and EU Good Manufacturing Practice (GMP) certificates are not publicly disclosed, the company's extensive product portfolio and global partnerships suggest a focus on meeting international standards. Exsell Laboratories' commitment to quality control measures and adherence to international standards make it a preferred choice for healthcare providers worldwide.

3CDSCO & Indian Regulatory

Exsell Laboratories Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Exsell Laboratories Private Limited operates in a competitive pharmaceutical export market, with numerous companies offering similar products across various therapeutic categories. While specific market share comparisons and head-to-head analyses are not publicly available, Exsell Laboratories' extensive product portfolio of over 36,000 items and its export activities to over 45 countries indicate a significant presence in the market. The company's commitment to quality and regulatory compliance, as evidenced by its partnerships with hospitals, pharmacies, and governments worldwide, positions it as a competitive player in the pharmaceutical export industry.

2Key Differentiators

Exsell Laboratories Private Limited distinguishes itself through its extensive product portfolio of over 36,000 certified medicines and medical supplies, catering to diverse therapeutic categories. The company's global presence, exporting to over 45 countries, demonstrates its adaptability and commitment to international business development. Exsell Laboratories' dedication to quality control measures and adherence to international standards, as evidenced by its partnerships with hospitals, pharmacies, and governments worldwide, further solidify its reputation as a reliable and trusted pharmaceutical exporter.

Strategic Position

Buyer Due Diligence Brief — Evaluating Exsell Laboratories Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Exsell Laboratories Private Limited has demonstrated a consistent track record in pharmaceutical exports, with a total export value of $28,000 USD across 29 shipments, indicating reliability and consistency in its export operations. The company's diverse product portfolio, including top products like Ribavirin, Ledipasvir, and Chlorambucil, reflects its capability to meet various market demands. Exsell Laboratories' partnerships with hospitals, pharmacies, and governments worldwide underscore its reliability and commitment to quality, making it a dependable supplier in the pharmaceutical export industry.

2Certifications to Verify

Importers should verify the following certifications when considering Exsell Laboratories Private Limited as a supplier:

FDA Registration: Confirm the company's FDA facility registrations to

TransData Nexus Research · FDA, WHO, EMA regulatory databasesMar 2026

Frequently Asked Questions — Exsell Laboratories Private Limited

How many pharmaceutical products does Exsell Laboratories Private Limited export from India?

Exsell Laboratories Private Limited exports 3 pharmaceutical products across 3 therapeutic categories. The top exports are Ribavirin ($15.2K), Ledipasvir ($9.8K), Chlorambucil ($3.3K). Total export value is $28.3K.

What is Exsell Laboratories Private Limited's total pharmaceutical export value?

Exsell Laboratories Private Limited's total pharmaceutical export value is $28.3K, based on 29 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Exsell Laboratories Private Limited cover?

Exsell Laboratories Private Limited exports across 3 therapeutic categories. The largest are Antivirals (53.7%, 1 products), Antiviral & HIV Medications (34.6%, 1 products), Advanced Oncology (11.6%, 1 products).

Get Full Exsell Laboratories Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.